AGP
ROIV icon

Artia Global Partners’s Roivant Sciences ROIV Stock Holding History

Artia Global Partners’s Portfolio ROIV Stock Details ROIV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$3.6M Hold
129,800
– – 0.72% 27
2025
Q4 		$2.82M Buy
+129,800
New +$2.56M 0.4% 33
2023
Q4 		– Sell
-914,023
Closed -$10.7M – 34
2023
Q3 		$10.7M Buy
914,023
+89,660
+11% +$1.01M 4.44% 8
2023
Q2 		$8.31M Buy
824,363
+666,600
+423% +$5.96M 2.86% 14
2023
Q1 		$1.16M Buy
+157,763
New +$1.3M 0.43% 26

Other funds holding ROIV

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
QF
QVT Financial New York $1.37B AUM 148.1% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Artia Global Partners's ROIV Position: Q1 2026 in Review

Artia Global Partners held its Roivant Sciences (ROIV) position steady in Q1 2026 at 129,800 shares worth $3.6M. The position accounts for 0.72% of the portfolio, ranked #27.

Artia Global Partners first reported a position in ROIV in Q1 2023 and has held it in 5 quarters since. The position peaked at $10.7M in Q3 2023. 439 funds tracked by Wall St. Rank hold ROIV as of Q1 2026.

  • Artia Global Partners held 129,800 shares of Roivant Sciences worth $3.6M as of Q1 2026.
  • Artia Global Partners left its Roivant Sciences share count unchanged in Q1 2026.
  • Roivant Sciences made up 0.72% of Artia Global Partners's portfolio in Q1 2026, its #27 holding.
  • Artia Global Partners first reported a position in Roivant Sciences in Q1 2023 and has held it in 5 quarters since.
  • Artia Global Partners's Roivant Sciences position peaked at $10.7M in Q3 2023.
  • 439 funds tracked by Wall St. Rank held Roivant Sciences as of Q1 2026.

Based on Artia Global Partners's 13F filing for Q1 2026, filed 15 May 2026.